Glycoprotein IIb-IIIa (alpha IIb beta 3) and the vitronectin receptor (alpha v beta 3), two integrins that share the common beta 3 subunit, have been reported to function as promiscuous receptors for the RGD-containing adhesive proteins fibrinogen, vitronectin, fibronectin, von Willebrand factor, and thrombospondin. The present study was designed to establish a cell system for the expression of either GP IIb-IIIa or the vitronectin receptor in an otherwise identical cellular environment and to compare the adhesive properties of these two integrins with those of native GP IIb-IIIa and the vitronectin receptor constitutively expressed in HEL cells or platelets. M21 human melanoma cells lack GP IIb-IIIa and use the vitronectin receptor to attach to vitronectin, fibrinogen, fibronectin, and von Willebrand factor. To study the functional properties of GP IIb-IIIa in these cells, we transfected GP IIb into M21-L cells, a variant of M21 cells (Cheresh, D.A., and R.C. Spiro. 1987. J. Biol. Chem. 262:17703-17711), which lack the expression of functional alpha v and are therefore unable to attach to vitronectin, fibrinogen, and von Willebrand factor. Transfectants expressing GP IIb were isolated by immunomagnetic beads and surface expression of the GP IIb-IIIa complex was documented by FACS analysis and immunoprecipitation experiments performed with 125I-labeled M21-L/GP IIb cells. Comparative functional studies demonstrated that GP IIb-IIIa expressed in M21-L/GPIIb cells as well as native GP IIb-IIIa constitutively expressed in HEL-5J20 cells (an HEL variant lacking alpha v beta 3) mediated cell attachment to immobilized fibrinogen, but not to vitronectin or von Willebrand factor, whereas the vitronectin receptor expressed in M21 cells and HEL-AD1 cells (an HEL variant expressing alpha v beta 3) mediated cell attachment to fibrinogen, vitronectin, and von Willebrand factor. Similarly, PGl2-treated resting platelets attached to immobilized fibrinogen but not to vitronectin or von Willebrand factor, and this attachment could be inhibited by mAb A2A9 (directed against a functional site on the GP IIb-IIIa complex). However, in contrast to platelets, which adhered to vitronectin and von Willebrand factor after stimulation by thrombin or PMA, activation of the protein kinase C pathway in M21-L/GP IIb or HEL cells did not induce cell adhesion to vitronectin or von Willebrand factor.(ABSTRACT TRUNCATED AT 400 WORDS)
Skip Nav Destination
Article navigation
15 April 1991
Article|
April 15 1991
Adhesive properties of the beta 3 integrins: comparison of GP IIb-IIIa and the vitronectin receptor individually expressed in human melanoma cells.
N Kieffer,
N Kieffer
COR Therapeutics Inc., South San Francisco, California 94080.
Search for other works by this author on:
L A Fitzgerald,
L A Fitzgerald
COR Therapeutics Inc., South San Francisco, California 94080.
Search for other works by this author on:
D Wolf,
D Wolf
COR Therapeutics Inc., South San Francisco, California 94080.
Search for other works by this author on:
D A Cheresh,
D A Cheresh
COR Therapeutics Inc., South San Francisco, California 94080.
Search for other works by this author on:
D R Phillips
D R Phillips
COR Therapeutics Inc., South San Francisco, California 94080.
Search for other works by this author on:
N Kieffer
COR Therapeutics Inc., South San Francisco, California 94080.
L A Fitzgerald
COR Therapeutics Inc., South San Francisco, California 94080.
D Wolf
COR Therapeutics Inc., South San Francisco, California 94080.
D A Cheresh
COR Therapeutics Inc., South San Francisco, California 94080.
D R Phillips
COR Therapeutics Inc., South San Francisco, California 94080.
Online ISSN: 1540-8140
Print ISSN: 0021-9525
J Cell Biol (1991) 113 (2): 451–461.
Citation
N Kieffer, L A Fitzgerald, D Wolf, D A Cheresh, D R Phillips; Adhesive properties of the beta 3 integrins: comparison of GP IIb-IIIa and the vitronectin receptor individually expressed in human melanoma cells.. J Cell Biol 15 April 1991; 113 (2): 451–461. doi: https://doi.org/10.1083/jcb.113.2.451
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement
Advertisement